| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6157942 | American Journal of Kidney Diseases | 2012 | 9 Pages |
Abstract
A 27-month course of EDTA chelation therapy retards the progression of diabetic nephropathy in type 2 diabetic patients with high-normal body lead burdens.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Kuan-Hsing MD, Ja-Liang MD, Dan-Tzu RN, Hsiang-Hao MD, Ching-Wei MD, Kuang-Hung PhD, Tzung-Hai MD,